Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys Limited (NSE: INFY, BSE: 500209, NYSE: INFY) spent December 3 trading firm against a weak broader market, with investors digesting fresh currency moves, a just-closed ₹18,000‑crore share buyback, and new tax headlines alongside steady Q2 FY26 earnings and a deepening AI pipeline. Infosys share price today: INFY holds firm as IT bucks the sell‑off Based on provisional end‑of‑day data, Infosys shares on the NSE closed around ₹1,583 per share on December 3, up roughly 1.4% versus the previous close of ₹1,561, with volume of about 6.7 million shares. Investing.com That move came on a day when India’s benchmark indices
3 December 2025
HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank Limited (NSE: HDFCBANK, BSE: 500180, NYSE: HDB) is trading almost flat on 3 December 2025, with investors weighing strong quarterly earnings against fresh regulatory headlines and higher capital requirements from the Reserve Bank of India (RBI).The Economic Times+1 Note: There is no separate “IHDFC Bank Limited” on the market — the listed entity is HDFC Bank Limited. 1. HDFC Bank share price today: where the stock stands India listing (NSE / BSE) Around midday on 3 December 2025, HDFC Bank shares are hovering close to ₹990–₹991, essentially flat after Monday’s profit‑taking.The Economic Times+1 Key near‑term stats from Indian
3 December 2025
Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea shares rose 3.65% to ₹10.51 by midday on December 3, 2025, with volumes topping 800 million as speculation grew over government relief for AGR dues. The stock has rebounded nearly 80% since its August low, after the Supreme Court allowed a reassessment of dues and the government became the largest shareholder with a 48.99% stake in April.
3 December 2025
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 03.12.2025

Amanat Holdings PJSC reported 330.2% earnings growth year over year, driven by a one-off AED68.3M gain, raising its net profit margin to 24.1%. The S&P BSE Sensex rose 110 points to 85,216.95, while the NSE Nifty 50 gained 41 points to 26,027.15 amid rupee weakness and FII outflows. Bitcoin held near $93,000 as soft US data fueled Fed rate cut bets; Asian stocks traded mixed.
3 December 2025
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health shares traded near $331 early December 3, about 30% below their 52-week high despite a strong Q3 earnings report. The stock is down 18% over the past year, underperforming the S&P 500. Q3 operating revenue rose 12% to $50.1 billion, with net income up nearly 18% to $1.2 billion. Shares fell 2.5% at the start of December before stabilizing.
3 December 2025
Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas Corporation closed at $184.19 on December 2, 2025, near its 52-week low and down about 17% over the past year, despite continued revenue growth and strong margins. Arrowstreet Capital, Panagora Asset Management, and Edgestream Partners have all increased their stakes in recent filings. Cintas’ market cap stands near $75 billion, with the stock trading at over 40 times trailing earnings.
3 December 2025
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M shares closed at $171.56 on December 2, 2025, near a four-year high and up about 31% over the past year. Technical models show short-term bullish momentum, but long-term forecasts from CoinCodex and StockScan project a possible decline to around $133 by 2026–2030. The company’s market cap stands at $91 billion with a dividend yield of 1.7%. Investors remain split over legal risks and recent gains.
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

A U.S. judge on Dec. 1, 2025, revived a $6.7 billion lawsuit against Bristol-Myers Squibb over Celgene contingent value rights, sending BMY shares down 1.89% to $48.25. The stock marked its third straight loss, underperforming peers as legal risks weighed despite positive hematology data at ASH 2025. Market cap stood at about $98 billion. Trading volume was below average at 14.5 million shares.
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management shares closed at $132.08 on December 2, 2025, up 0.53%, with after-hours trading lifting the price to $132.80. The firm confirmed $908 billion in assets under management as of September 30. CEO Marc Rowan is set to appear at the Goldman Sachs US Financial Services Conference on December 10. Apollo’s market cap stood at about $76.3 billion.
3 December 2025
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health shares fell 1.9% to $77.62 on December 2, 2025, underperforming the S&P 500 and healthcare peers after news of a $37.76 million federal settlement over insulin-pen billing. Trading volume topped 7.7 million shares, above average. The stock remains up about 75–80% for the year but sits roughly 8–9% below its late October high. CVS did not admit liability in the settlement.
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group Inc. (NASDAQ: CME), the world’s largest derivatives exchange operator, has packed a lot of news into the turn of the month. On December 2, 2025, the company reported near-record trading volumes, secured U.S. regulatory approval for a new securities clearing house, and continued to deal with the reputational fallout from last week’s rare 10‑hour trading outage. At the same time, options traders and Wall Street analysts are re‑positioning around the stock. This article brings together all the major CME stock news, forecasts and analyses dated December 2, 2025 (and closely related developments) to give you a single, SEO‑friendly
3 December 2025
ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (NYSE: COP) heads into the final month of 2025 as one of the most hotly debated energy stocks on Wall Street. On Tuesday, December 2, 2025, COP closed at $89.29, down 1.07% on the day, even as the S&P 500 and Dow Jones notched modest gains. That leaves the stock about 17% below its 52‑week high of $107.67, reached on December 3 last year, and still in the lower half of its trading range between $79.88 and $108.74. MarketWatch+1 Yet analysts broadly agree the stock may be trading at a discount: consensus 12‑month price targets cluster around $113–$116, implying
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare, Inc. (NYSE:HCA) is ending 2025 on a powerful note. After a year of double‑digit earnings growth and upgraded guidance, HCA stock is trading just above $500 per share, close to its 52‑week high of $520 and implying a market capitalization around $117 billion. MarketBeat On November 25, the stock touched an all‑time high of $515.85, and as of December 2 it was still near $503, more than 38% above its July 2024 peak of $363.05 — a rally powered by strong results from the company’s 191‑hospital network and an aggressive capital program. Becker’s Hospital Review This article rounds
3 December 2025
Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation closed at US$46.46 on the NYSE and C$65.01 on the TSX on December 2, 2025, valuing the company at over US$100 billion. HSBC Holdings increased its stake by 3.7% in Q2, while institutional ownership in Brookfield now exceeds 60%. The board declared a US$0.06 quarterly dividend, payable December 31. BN shares are up about 16% over the past year.
Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings shares surged nearly 5% on December 2, 2025, closing at $5,135.07 after Q3 results beat expectations and management raised guidance. Several institutional investors disclosed new 13F filings the same day, with some increasing and others reducing positions. Wall Street targets imply 19–21% upside, but technical models warn of a possible 14% pullback in the next three months.
TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX shares closed at $150.02 on December 2, 2025, just below their record high of $154.66, giving the retailer a market cap near $167 billion. The stock has climbed over 26% year-to-date, hitting an all-time high on November 26. Technical analysts downgraded TJX from “Buy” to “Hold/Accumulate” after a three-day slide. Volatility remains low, with daily moves averaging under 2% last week.
BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock, Inc. (NYSE: BLK), the world’s largest asset manager, entered December 2025 at the center of several powerful themes: the AI infrastructure build‑out, a booming Bitcoin ETF franchise, shifting views on long‑term Treasuries, and intensifying ESG politics. On 2 December 2025, BLK shares closed at about $1,038.62, down a modest 0.13% on the day and roughly flat for the year, even as Wall Street price targets still point to double‑digit upside. Investing.com+1 Below is a detailed rundown of the latest price action, key news, forecasts, and analyses as of 2 December 2025. 1. How BlackRock (BLK) Traded on 2 December
Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce (CRM) Stock: Price Today, AI Strategy and 2030 Forecast Ahead of Q3 Earnings — December 2, 2025

Salesforce, Inc. (NYSE: CRM) heads into a pivotal earnings week with its share price hovering in the mid‑$230s and Wall Street laser‑focused on whether the company’s big bet on AI and “agentic” workflows can re‑ignite growth. As of the close on December 2, 2025, Salesforce stock traded around $234.71, up roughly 0.8% on the day, with after‑hours quotes inching closer to $235.69. StockAnalysis Below is a comprehensive look at the latest price action, fresh analyst forecasts, institutional moves, and AI‑driven strategy updates, based on coverage and filings published up to December 2, 2025. Salesforce (CRM) stock price today and recent
3 December 2025
Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton shares closed at $333 on December 2, 2025, down 1.9% for the day and 16% below their 52-week high, despite record Q3 earnings and margins. The stock has fallen 11% over the past year, underperforming the S&P 500 and industrial peers. Eaton recently agreed to acquire Boyd Thermal for $9.5 billion and is expanding U.S. manufacturing amid strong demand from AI and electrification trends.
3 December 2025

Stock Market Today

ASML stock price jumps as AI spending race returns; jobs data and dividend dates ahead

ASML stock price jumps as AI spending race returns; jobs data and dividend dates ahead

8 February 2026
ASML’s U.S.-listed shares jumped 4.6% to $1,413 on Friday, tracking a 5.7% rally in chip stocks after Amazon and Alphabet signaled higher AI infrastructure spending. Peers Applied Materials, Lam Research, and KLA each gained over 6%. ASML’s interim dividend goes ex-dividend Feb. 9 in Amsterdam and Feb. 10 in New York, with payment set for Feb. 18. U.S. jobs and inflation data are due next week.
Ashtead Group share price ends week higher as U.S. listing clock ticks — what to watch next

Ashtead Group share price ends week higher as U.S. listing clock ticks — what to watch next

8 February 2026
Ashtead Group shares closed up 1.1% at 4,936 pence Friday after the company confirmed a new round of share buybacks. The firm expects its U.S. listing to become effective Feb. 26, with a UK share swap on Feb. 27 and new shares trading March 2. FTSE Russell plans to remove Ashtead from its UK indexes from March 2. Index funds are preparing for the change as the company shifts its primary listing to New York.
Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

Beazley share price sits below Zurich’s £8bn offer — what to watch before London reopens

8 February 2026
Beazley shares closed flat at 1,236 pence Friday as Zurich faces a Feb. 16 deadline to make a firm takeover offer or withdraw. Zurich and Beazley have agreed in principle on key terms valuing Beazley at up to 1,335 pence per share. Recent filings show Vanguard and FMR LLC among top shareholders. The shares remain below the possible offer price as due diligence continues.
Tesco share price: what to watch after Friday’s close as rate and wage bets shift

Tesco share price: what to watch after Friday’s close as rate and wage bets shift

8 February 2026
Tesco shares closed at 452.10 pence on Friday, up 0.62%, as UK markets ended the week higher. Investors weighed Bank of England signals on interest rates and rising supermarket wage costs, with Lidl and rivals announcing pay increases ahead of April’s minimum wage hike. Morrisons is considering raising up to £1 billion against its store portfolio, according to Sky News. Tesco continues its share buyback program after a January profit forecast upgrade.
Go toTop